• Explore /
  • Poster
  • / Comparison of 5-FU versus capecitabine in combination with mitomycin or cisplatin in the treatment of anal cancer.

Comparison of 5-FU versus capecitabine in combination with mitomycin or cisplatin in the treatment of anal cancer.

Abstract Poster

Authors

null

Irene S. Yu

British Columbia Cancer Agency, Vancouver, BC, Canada

Irene S. Yu , Winson Y. Cheung

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 35, 2017 (suppl 4S; abstract 680)

DOI

10.1200/JCO.2017.35.4_suppl.680

Abstract #

680

Poster Bd #

H10

Abstract Disclosures

Similar Posters

First Author: Shilpa Gupta

First Author: Marcia Hall

Poster

2018 Gastrointestinal Cancers Symposium

A 20-year comparison of definitive chemoradiation with 5-FU versus capecitabine in anal cancer patients treated at Stanford.

A 20-year comparison of definitive chemoradiation with 5-FU versus capecitabine in anal cancer patients treated at Stanford.

First Author: Yoanna S Pumpalova

First Author: Suilane Coelho Ribeiro